Initiation of Home Mechanical Ventilation at Home in a Selectve Group of Patients With Chronic Hypercapnic Respiratory Failure in the Netherlands
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Respiratory Therapy
- Sponsor
- University Medical Center Groningen
- Enrollment
- 96
- Locations
- 1
- Primary Endpoint
- Daytime arterial carbon dioxide
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
Objective: To prove that initiation of chronic ventilatory support at home, in patients with chronic hypercapnic respiratory failure due to neuromuscular disease (NMD) or thoracic cage problem is not inferior compared to initiation in a hospital based setting. In addition we believe that the start at home is cheaper compared to an in-hospital start.
Hypothesis: Initiation of chronic ventilatory support at home is effective, safe and cost effective compared to a hospital-based initiation.
Study design: A nationwide non-inferiority multi-center randomized parallel active control study.
Study population: Patients with chronic respiratory insufficiency due to a neuromuscular disease (NMD) or thoracic cage problem who are referred for chronic ventilator support.
Intervention: The start of HMV at home Standard intervention to be compared to: The start of HMV is normally in a clinical setting as recommended in the national guideline.
Outcome measures: Primary: PaCO2. Secondary: Health related quality of life; lung function; nocturnal transcutaneous carbon dioxide assessment and saturation, and costs Sample size calculation/data analysis: This is a non-inferiority trial based on PaCO2 as primary outcome. A difference in favor of the hospital care group of smaller than 0.5 kPa will be labeled as non-inferior. To retain 72 evaluable patients, and allow for drop-outs, we will include 96 patients in total.
Cost-effectiveness analysis: A cost analysis will be conducted alongside the clinical trial. Costs of the initiation of HMV at home and in the hospital will be estimated form a societal perspective over a time horizon of 6 months.
Time schedule: After an initial phase of 6 months recruitment will start and will take 24 months. Thirty-six months after the start of the study the last assessments will be done and analysis and writing of the papers will start. After 42 months the study will end.
Investigators
Peter Wijkstra
professor
University Medical Center Groningen
Eligibility Criteria
Inclusion Criteria
- •Indication to initiate non-invasive ventilatory support in patients with a neuromuscular disease or thoracic cage abnormality who suffer from complaints of alveolar hypoventilation (fatigue, headache of dyspnoea) combined with all following elements:
- •arterial carbon dioxide \> 6.0 kPa daytime or arterial or transcutaneous carbon dioxide \> 6.0 kPa at night or orthopnea as a result of diaphragm paralysis
- •Age \> 18 years
- •Existence, of a sufficient network (social or professional) according to the supervising HMV center making initiation of HMV at home possible and safe.
Exclusion Criteria
- •Patients who already have had HMV due to acute respiratory failure
- •Necessity for invasive ventilatory support
- •Patients admitted to a nursing home
Outcomes
Primary Outcomes
Daytime arterial carbon dioxide
Time Frame: 6 months after initiation of mechanical ventilation
Daytime arterial carbon dioxide (PaCO2) assessed without oxygen supplementation and ventilatory support while the patient is in sitting position
Secondary Outcomes
- Lung function(6 months after initation of mechanical ventilation)
- Quality of life(6 months after initiation of mechanical ventilation)
- Nocturnal transcutaneous carbon dioxide and saturation(6 months after initiation of mechanical ventilation)
- costs(6 months after initiation of mechanical ventilation)